Mark T. Iwicki is Director at Kala Pharmaceuticals, Inc. (KALA). They have made 5 open-market trades across 2 companies since 2015, most recently 2025-12-12.
CIK 0001415537
2 open-market purchases totalling $620K since 2015, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRUS | 36,944 | $3.3M |
| AIMT | 47,407 | $1.6M |
| AKRO | 9,398 | $514K |
| PULM | 307,000 | $419K |
| KALA | 103,540 | $19K |
| SEPR | 122,334 | — |
| Total | $5.9M |
Shares reported on the most recent Form 4, priced at the 2025-10-24 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALA | SELL | 2025-10-23 | 2025-10-24 | $0.81 | $251K | -3.9% | -22.2% | -25.6% |
| KALA | SELL | 2025-06-24 | 2025-06-26 | $4.01 | $106K | +16.5% | +46.6% | +253.7% |
| KALA | SELL · 10b5-1 | 2025-06-03 | 2025-06-05 | $3.74 | $41K | +0.5% | +26.9% | +260.8% |
| KALA | SELL · 10b5-1 | 2025-01-06 | 2025-01-07 | $7.63 | $44K | +2.5% | +43.3% | -50.1% |
| KALA | SELL | 2024-06-26 | 2024-06-27 | $4.75 | $72K | +13.1% | +5.2% | -18.8% |
| KALA | SELL · 10b5-1 | 2024-05-31 | 2024-06-03 | $6.09 | $45K | -11.9% | +0.1% | -13.5% |
| KALA | SELL · 10b5-1 | 2024-01-04 | 2024-01-05 | $6.73 | $31K | +20.4% | -0.4% | +10.8% |
| KALA | SELL · 10b5-1 | 2023-01-04 | 2023-01-06 | $28.54 | $6K | -35.8% | -41.0% | -50.1% |
| KALA | SELL · 10b5-1 | 2022-10-26 | 2022-10-28 | $6.52 | $4K | +6.5% | -6.5% | +215.1% |
| KALA | SELL · 10b5-1 | 2022-06-27 | 2022-06-29 | $0.37 | $3K | +8.1% | +6.5% | -24.5% |
| KALA | SELL · 10b5-1 | 2022-01-04 | 2022-01-05 | $1.30 | $12K | -19.1% | -32.1% | +5.2% |
| KALA | SELL · 10b5-1 | 2021-10-26 | 2021-10-28 | $1.80 | $50K | +23.6% | +6.3% | -51.0% |
| KALA | SELL · 10b5-1 | 2021-06-28 | 2021-06-29 | $5.77 | $44K | -16.9% | -35.1% | -44.9% |
| AIMT | BUY | 2018-02-26 | 2018-02-26 | $32.00 | $300K | +12.1% | +2.9% | +4.8% |
| AIMT | BUY | 2015-08-11 | 2015-08-11 | $16.00 | $320K | -20.8% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.